title: Hepatocellular carcinoma in elderly patients: challenges and solutions.
abstract: Hepatocellular carcinoma (HCC) is the second most common cause of death by cancer in the world. Due to the delayed HCC development in hepatitis C carriers and nonalcoholic fatty liver disease, the incidence of HCC in the elderly is increasing and is becoming a global health issue. Elderly patients with HCC should be assessed through proper oncologic approach, namely, screening tools for frailty (Geriatric-8 or Vulnerable Elders Survey-13) and comprehensive geriatric assessment. This review of the literature supports the same treatment options for elderly patients as for younger patients, in elderly patients selected as fit following proper oncogeriatric assessment. Unfit patients should be managed through a multidisciplinary team involving both oncological and geriatrician professionals. Specific studies and recommendations for HCC in the elderly should be encouraged.
authors: Department of Medical Oncology, Centre Eugene Marquis, Rennes, France.
authors: Angélique
authors: A
authors: Brunot
authors: Department of Medical Oncology, Centre Eugene Marquis, Rennes, France.
authors: Samuel
authors: S
authors: Le Sourd
authors: Department of Medical Oncology, Centre Eugene Marquis, Rennes, France.
authors: Marc
authors: M
authors: Pracht
authors: Department of Medical Oncology, Centre Eugene Marquis, Rennes, France.
authors: Julien
authors: J
authors: Edeline
keywords: geriatric evaluation; liver cancer; sorafenib; surgery; treatment